According to Bruker's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 38.2212. At the end of 2022 the company had a P/E ratio of 34.2.
Year | P/E ratio | Change |
---|---|---|
2022 | 34.2 | -25.47% |
2021 | 45.9 | -12.75% |
2020 | 52.6 | 31.98% |
2019 | 39.8 | 53.82% |
2018 | 25.9 | -62.29% |
2017 | 68.6 | 207.88% |
2016 | 22.3 | -43.96% |
2015 | 39.8 | -31.05% |
2014 | 57.7 | 40.11% |
2013 | 41.2 | 27.02% |
2012 | 32.4 | 46.2% |
2011 | 22.2 | -21.17% |
2010 | 28.1 | 16.65% |
2009 | 24.1 | 138.81% |
2008 | 10.1 | -58.23% |
2007 | 24.2 | -42.04% |
2006 | 41.7 | -39.91% |
2005 | 69.4 | -151.68% |
2004 | -134 | 509.36% |
2003 | -22.0 | -26.66% |
2002 | -30.1 | -92.65% |
2001 | -409 |
Company | P/E ratio | P/E ratio differencediff. | Country |
---|---|---|---|
Thermo Fisher Scientific TMO | 35.7 | -6.66% | ๐บ๐ธ USA |
Agilent Technologies A | 35.1 | -8.09% | ๐บ๐ธ USA |
Ametek AME | 32.0 | -16.22% | ๐บ๐ธ USA |
General Electric GE | 18.2 | -52.36% | ๐บ๐ธ USA |
Illumina ILMN | -4.45 | -111.63% | ๐บ๐ธ USA |
Waters Corporation WAT | 26.7 | -30.13% | ๐บ๐ธ USA |
Danaher DHR | 29.8 | -21.90% | ๐บ๐ธ USA |
PerkinElmer
PKI | 15.0 | -60.84% | ๐บ๐ธ USA |
Accelerate Diagnostics AXDX | -0.0936 | -100.24% | ๐บ๐ธ USA |
Bio-Rad Laboratories BIO | -50.8 | -233.04% | ๐บ๐ธ USA |
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.